Wed, Oct 1, 2014
A A A
Welcome sandeep.kottawar@wns.com
RSS

Sovereign Wealth Funds Briefing - Categorized | Investment

Japan’s Meiji buying Temasek-backed drugmaker Medreich for $290M

Posted on 13 June 2014

Meiji Seika Pharma, a part of Meiji Holdings Co. Ltd, has signed a deal to acquire Medreich Ltd, a Bangalore-based contract manufacturing pharmaceutical company, for $290 million (Rs 1,720 crore). This acquisition will also mark an exit for Singapore’s sovereign fund Temasek, which had invested in the company way back in 2005.
One source said Temasek held close to 33 per cent in Medreich, which it had picked through an allotment nine years ago for around Rs 112 crore ($25 million). This means it is exiting with 5.1x in local currency and 3.9x in dollar terms in its nine-year-old bet on the firm………………………………………..Full Article: Source


 Article link

This post was written by:

VRS - who has written 14855 posts on Opalesque Sovereign Wealth Funds Briefing.


Contact the author

Comments are closed.

banner
October 2014
M T W T F S S
« Sep    
 12345
6789101112
13141516171819
20212223242526
2728293031